The p53 tumor suppressor protein is a key cellular regulatory component implicated in the control of cell growth and death. An essential determinant in the ability of p53 to mediate its multiple functions lies in it stability. The applicant has studied mechanisms underlying the regulation of p53 stability. Preliminary results show that in nonstressed cells p53 ubiquitinaton and degradation is regulated by its associated kinase, Jun-NH2 kinase (JNK), in an mdm2 independent manner. This finding provides the foundation for the applicants' hypothesis that JNK targeting of p53 ubiquitinations and degradation is central to p53 stability. To test this hypothesis the applicant proposes to: (1) identify which of the JNK isozymes is involved in the regulation of p53 stability; (2) determine the role of JNK in HPV16-E6- dependent ubiquitination and degradation of p53; (3) find which of p53- stabilitzing agents/stimuli affect JNK in the regulation of p53 stability; (4) elucidate the contribution of post-translational modifications by phosphorylation and acetylation of p53 to JNK targeting of its stability; and (5) identify domains of JNK that mediate its regulation of p53 stability. The proposed studies will be performed using novel in vitro ubiquitination and in vitro degradation assays and will be confirmed via respective in vivo assays. Successful completion of the proposed studies will provide substantial new knowledge as per the mechanisms underlying the regulation of p53 stability and possible means for altering the stability of this important tumor suppressor protein.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA078419-05
Application #
6513274
Study Section
Special Emphasis Panel (ZRG2-SSS-1 (05))
Program Officer
Blair, Donald G
Project Start
1998-07-01
Project End
2003-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
5
Fiscal Year
2002
Total Cost
$291,077
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Chen, Meifan; Gutierrez, Gustavo J; Ronai, Ze'ev A (2012) The anaphase-promoting complex or cyclosome supports cell survival in response to endoplasmic reticulum stress. PLoS One 7:e35520
Chen, Meifan; Gutierrez, Gustavo J; Ronai, Ze'ev A (2011) Ubiquitin-recognition protein Ufd1 couples the endoplasmic reticulum (ER) stress response to cell cycle control. Proc Natl Acad Sci U S A 108:9119-24
Zhang, Laiqun; Blackwell, Ken; Altaeva, Aliya et al. (2011) TRAF2 phosphorylation promotes NF-?B-dependent gene expression and inhibits oxidative stress-induced cell death. Mol Biol Cell 22:128-40
Zhang, Laiqun; Blackwell, Ken; Shi, Zhaohui et al. (2010) The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB. J Mol Biol 396:528-39
Gutierrez, Gustavo J; Tsuji, Toshiya; Cross, Janet V et al. (2010) JNK-mediated phosphorylation of Cdc25C regulates cell cycle entry and G(2)/M DNA damage checkpoint. J Biol Chem 285:14217-28
Gutierrez, Gustavo J; Tsuji, Toshiya; Chen, Meifan et al. (2010) Interplay between Cdh1 and JNK activity during the cell cycle. Nat Cell Biol 12:686-95
Blackwell, Ken; Zhang, Laiqun; Thomas, Gregory S et al. (2009) TRAF2 phosphorylation modulates tumor necrosis factor alpha-induced gene expression and cell resistance to apoptosis. Mol Cell Biol 29:303-14
Zhang, Laiqun; Blackwell, Ken; Thomas, Gregory S et al. (2009) TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells. J Mol Biol 389:495-510
Topisirovic, Ivan; Gutierrez, Gustavo J; Chen, Meifan et al. (2009) Control of p53 multimerization by Ubc13 is JNK-regulated. Proc Natl Acad Sci U S A 106:12676-81
Thomas, Gregory S; Zhang, Laiqun; Blackwell, Ken et al. (2009) Phosphorylation of TRAF2 within its RING domain inhibits stress-induced cell death by promoting IKK and suppressing JNK activation. Cancer Res 69:3665-72

Showing the most recent 10 out of 34 publications